Abstract:Primary graft dysfunction (PGD) and chronic lung allograft dysfunction (CLAD) are critical challenges in lung transplantation. Dysregulated gene expression and epigenomic states in lung mesenchymal cells (MCs) play a key role in these conditions, but further work is needed to elucidate the biomarkers and molecular drivers. Single-cell multi-omic technologies offer an unprecedented opportunity to address this gap by jointly measuring gene expression and chromatin accessibility in diseased and healthy cells. We performed single-cell multi-omic profiling and genetic demultiplexing on MCs isolated from human bronchoalveolar lavage samples of lung transplant recipients with CLAD and PGD, compared with time-matched controls. A classification model trained on these profiles classified the disease status of individual cells with > 98% accuracy using a small set of signature genes. We further identified 8 subtypes of MCs each characterized by distinct transcriptomic and epigenomic signatures, including a CLAD-enriched subtype and a PGD-enriched subtype. The CLAD-enriched subtype expresses markers of fibrosis, while the PGD-enriched subtype expresses pro-inflammatory genes. Finally, we used co-accessibility and co-expression to identify C/EBPD, SOX4, and FOXP2 as key regulators of the genes and chromatin accessibility peaks that are dysregulated in the CLAD-enriched cell population. Knocking down C/EBPD with siRNA partially reverted the CLAD gene expression signature, confirming the importance of this factor in the dysregulated molecular state of CLAD-associated MCs. Additional scRNA-seq analysis of MCs from human lung autopsy samples showed that cultured MCs retained key transcriptomic signatures from their in vivo counterparts. Sub-clustering analysis identified a CLAD-enriched MC sub-cluster with high C/EBPD expression, further linking these cells to the fibrotic state seen in vitro. Our results provide deeper insights into the transcriptomic and epigenomic changes in post-transplant MCs, nominating biomarkers and disease-associated factors with implications for future therapeutic efforts.

Update on the immunological mechanisms of primary graft dysfunction and chronic lung allograft dysfunction

Primary Graft Dysfunction in Lung Transplantation: A Review of Mechanisms and Future Applications

A Focused Review on Primary Graft Dysfunction after Clinical Lung Transplantation: A Multilevel Syndrome

Lymphocytic Airway Inflammation in Lung Allografts

Mitigating the risk of inflammatory type primary graft dysfunction by applying an integrated approach to assess, modify and match risk factors in lung transplantation

Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation

The diagnosis and management of chronic lung allograft dysfunction

The role of lung-restricted autoantibodies in the development of primary and chronic graft dysfunction

Lung Innate Lymphoid Cell Composition Is Altered in Primary Graft Dysfunction

Innate immunity in lung transplantation

The Immunopathology of Pulmonary Rejection after Murine Lung Transplantation

Impaired complement regulation drives chronic lung allograft dysfunction after lung transplantation.

Murine orthotopic lung transplant models: A comprehensive overview of genetic mismatch degrees and histopathological insights into chronic lung allograft dysfunction

Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunction

Ex Vivo Lung Perfusion and Primary Graft Dysfunction Following Lung Transplantation: A Contemporary United Network for Organ Sharing Database Analysis

Downregulation of Tumor Suppressor Gene LKB1 During Severe Primary Graft Dysfunction After Human Lung Transplantation: Implication for the Development of Chronic Lung Allograft Dysfunction

Analysis of Primary Graft Dysfunction (PGD) Risk Factors in Lung Transplantation (LuTx) Patients

Lung transplantation in adults and children: putting lung function into perspective

Single-cell multi-omic analysis of post-transplant mesenchymal cells reveals molecular signatures and putative regulators of lung fibrosis

NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation outcomes

Short airway telomeres are associated with primary graft dysfunction and chronic lung allograft dysfunction